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Abstract:  A series of 7-hydroxy, 8-hydroxy and 7,8-dihydroxy synthetic chromone 
derivatives was evaluated for their DPPH free radical scavenging activities.  A training set 
of 30 synthetic chromone derivatives was subject to three-dimensional quantitative 
structure-activity relationship (3D-QSAR) studies using molecular field analysis (MFA). 
The substitutional requirements for favorable antioxidant activity were investigated and a 
predictive model that could be used for the design of novel antioxidants was derived.   
Regression analysis was carried out using genetic partial least squares (G/PLS) method.   
A highly predictive and statistically significant model was generated.  The predictive ability 
of the developed model was assessed using a test set of 5 compounds (r
2
pred = 0.924).     
The analyzed MFA model demonstrated a good fit, having r
2 value of 0.868 and cross-
validated coefficient r
2
cv value of 0.771. 
Keywords: 3D-QSAR, Chromone, Molecular field analysis (MFA), Antioxidants, Genetic 
partial least squares (G/PLS) method. 
 
1.  Introduction  
Free radicals containing major species of reactive oxygen species (ROS) and/or reactive nitrogen 
species (RNS) are generated inside the living cells by exposure to several endogenous and exogenous Int. J. Mol. Sci. 2008, 9                           
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agents. They are known to cause permanent damages to biomolecules as implicated in several diseases 
or symptoms e.g. arteriosclerosis, Alzheimer's disease, cancer, and even aging [1-6].  Consequently, 
free radical scavengers are considered to be prospects as protective or therapeutic agents against such 
diseases. Flavonoids are naturally occurring compounds in a class of benzo-γ-pyrone derivatives 
ubiquitously found in plants.  They possess a wide spectrum of biological activities.  Some flavonoids 
have been reported to possess anticancer, anti HIV, anti-inflammatory, and several other activities  
[7-9].  Recent interests in these substances have been stimulated by potential health benefits arising 
from the antioxidant activity of polyphenolic flavonoids [10,11]. These are the result of their high 
propensity to transfer electrons, to chelate ferrous ions, and to scavenge reactive oxygen species   
[12-13].  Structure-activity relationship (SAR) studies of natural flavonoids demonstrate that the 
dissociation of hydroxyl functions occurs in the following sequence: 7-OH > 4′-OH > 5-OH [14].  The 
o-dihydroxy structure in the B ring, the 2,3-double bond in conjugation with the 4-oxo function in the 
C ring of flavone (Figure 1), and the 3- and 5-OH groups with the 4-oxo function in A and C rings are 
essential for effective free radical scavenging activity [15]. 
 
Figure 1. General flavone structure. 
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The chromone derivatives were synthesized and tested for their radical scavenging activities.   
Substitution of benzoyl group at position 3 in some compounds increased the number of conjugation 
bonds and improved the radical stabilization of flavonoids [16].  A number of SAR and QSAR studies 
have been performed on the antioxidant activity of natural chromone derivatives [17-22]. However, 
synthetic chromone derivatives have not been investigated. Therefore, the aim of this study was to 
explore the substitutional requirements of synthetic chromone derivatives as antioxidants to obtain a 
highly predictive 3D-QSAR model.  3D-QSAR analysis was performed using the most widely used 
computational tool, molecular field analysis (MFA) with respect to the steric and electrostatic 
influences.   
MFA is a method implemented in the Cerius
2 program.  Its formalism calculates probe interaction 
energies on a rectangular grid around a bundle of active molecules. The surface is generated from a 
“shape field.” The atomic coordinates of the contributing models are used to compute field values on 
each point of a 3D grid. MFA then evaluates the energy between a probe (H
+, CH3, and 
donor/acceptor) and a molecular model at a series of points defined by a rectangular grid.  Fields of 
molecules are represented with grids in MFA and corresponding energy associated with an MFA grid 
point can serve as input for the calculation of a QSAR. These energies are added to the study table to Int. J. Mol. Sci. 2008, 9                           
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form new columns headed according to the probe type.  Because of the large number of points used as 
independent variables, genetic partial least squares (G/PLS) is generally used to derive the QSAR 
models [23].  The best model is selected based on statistical measures such as data points (n), 
correlation coefficient (r), square correlation coefficient (r
2), cross-validated correlation coefficient 
(r
2
cv), predicted correlation coefficient (r
2
pred), predicted sum of squares (PRESS), bootstrap correlation 
coefficient (r
2
BS) and least-square error of fit (LSE).   
In this study, we evaluated the in vitro free radical scavenging activities of chromone derivatives by 
DPPH assay. Molecular field analysis (MFA) was carried out on a set of 36 synthetic chromone 
derivatives. 
2.  Results and Discussion   
2.1 Structure-radical scavenging activity relationship 
Thirty-six synthetic chromone derivatives (indicated as compounds 1-36) were assessed for their 
antioxidant activities by DPPH radical scavenging assay.  As shown in Tables 1 and 2, various 
chromones exhibited different levels of activity, ranging from EC50 = 2.58 to 182.77 µM which are 
more potent than the well known natural antioxidants, e.g., quercetin and luteolin which possessed 
IC50 = 10.89 and 11.04 µM, respectively [24].   Structure-radical scavenging activity relationship 
demonstrated that the 7,8-dihydroxy-2-phenyl-3-benzoyl substituted compounds (compounds 29, 30 
and 36) exhibited a strong antioxidant activity with low log EC50.  This indicated that dihydroxy 
substitution (cathecol group) on ring A was essential for radical scavenging activity.  The presence of 
benzoyl group at position 3 confers a high degree of stability toward the phenoxy radicals by 
participating in electron delocalization and thus is an important feature for potential antiradical 
property.  The proposed model for the progression of successive dehydrogenation from a hydroxyl 
chromone molecule using adjacent OH-containing aromatic ring is shown in Figure 2.  The initial 
dehydrogenation occurs on the para-OH group.  If this is the case, prototropy from an adjacent OH 
group will be easy.  This semiquinone type radical is more reactive than the original phenol molecule, 
so the second hydrogen liberation proceeds rapidly, thus resulting in biradical changes into a quinone.   
 
Table 1. Molecular structures and corresponding antioxidant activities of synthetic 
chromones (Training set). 
O
O
R2
R3
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Cpd R2 R 3 R 5 R 7 R 8 
EC50 log  EC50  
Residuals 
(µM) Actual Calculated 
1  Phenyl H  H  H  OH  96.18  1.983  2.046  0.063 
2  Phenyl H  H  OH  H  125.62  2.099  2.053  0.046 
3  Benzyl H  H  OH  H  125.09  2.097  1.964  0.133 
4  4′-(NO2)-Phenyl H  H  OH  H  101.89  2.008  1.888  0.120 Int. J. Mol. Sci. 2008, 9                           
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5  3′-(CF3)-Phenyl H  H  OH  H  93.37  1.970  2.315  -0.345 
6  4′-(F)-Phenyl H  H  OH  H  113.22  2.054  2.172  -0.118 
7  3′,5′-(diNO2)-Phenyl H  H  OH  H  87.45  1.942  1.962  -0.020 
8  3′-(Cl)-Phenyl H  H  OH  H  117.08  2.068  2.035  0.034 
9  4′-(t-butyl)-Phenyl H  H  OH  H  104.56  2.019  2.064  -0.045 
10  Phenyl CH3 H  OH  H  124.19  2.094  1.780  0.314 
11  Benzyl CH3 H  OH  H  123.47  2.092  2.074  0.018 
12  4′-(NO2)-Phenyl 4″-(NO2)-Benzoyl H  OH  H  59.30  1.773  1.600  0.173 
13  3′-(CF3)-Phenyl 3″-(CF3)-Benzoyl H  OH  H  54.32  1.735  1.637  0.098 
14  4′-(F)-Phenyl 4″-(F)-Benzoyl H  OH  H  72.53  1.860 1.709  0.151 
15  3′,4′-(diF)-Phenyl 3″,4″-(diF)-Benzoyl H  OH  H  63.00  1.799  1.710  0.089 
16  4′-(OCH3)-Phenyl 4″-(OCH3)-Benzoyl H  OH  H  70.80  1.850  2.047  -0.197 
17  3′-(CF3)-Phenyl H  OH  OH  H  85.46  1.932  1.806  0.126 
18  4′-(F)-Phenyl H  OH  OH  H  102.21  2.010  2.043  -0.034 
19  3′,4′-(diF)-Phenyl H  OH  OH  H  98.53  1.994  2.005  -0.016 
20  4′-(t-butyl)-Phenyl H  OH  OH  H  87.36  1.941  2.002  -0.061 
21  3′-(Cl)Phenyl H  OH  OH  H  104.30  2.018  2.014  0.004 
22  3′,4′-(diCl)-Phenyl H  OH  OH  H  90.19  1.955  1.823  0.132 
23  4′-(OCH3)-Phenyl H  OH  OH  H  109.37  2.039  1.999  0.040 
24  3′-(OCH3)-Phenyl H  OH  OH  H  111.62  2.048  2.040  0.008 
25  3′,5′-(diNO2)-Phenyl H  OH  OH  H  79.74  1.902  1.766  0.136 
26  4′-(NO2)-Phenyl 4″-(NO2)-Benzoyl OH  OH  H  57.54  1.756  1.860  -0.104 
27  Phenyl  H  H OH  OH 31.89 1.504  1.803  -0.300 
28  Benzyl  H  H OH  OH 38.12 1.581  1.615  -0.034 
29  3′-(CF3)-Phenyl 3″-(CF3)-Benzoyl H  OH  OH  2.58  0.417  0.589  -0.177 
30  4′-(F)-Phenyl 4″-(F)-Benzoyl H  OH  OH  3.93  0.594 0.707  -0.113 
 
Table 2. Structures and their corresponding antioxidant activities of synthetic chromones 
(Test set); * An outlier compound 
Cpd R2 R 3 R 5 R 7 R 8 
EC50 log  EC50  
Residuals 
(µM) Actual Calculated 
  31  CH3 H  H  OH H 182.77 2.262  2.324  -0.062 
32  3′,4′-(diCl)-Phenyl H  H  OH H 100.22 2.001  1.850  0.151 
33  4′-(NO2)-Phenyl H  H  OH H  90.43 1.956  1.856  0.100 
34  CH3 H  H  OH OH  41.25 1.616  2.084  -0.468 
35  3′-(OCH3)-Phenyl 3″-(OCH3)-Benzoyl  H  OH H  70.31 1.847  2.139  -0.292 
  36*  4′-(NO2)-Phenyl 4″-(NO2)-Benzoyl  H  OH OH  3.37 0.528  1.475  0.947 
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Figure 2. Resonance stabilization of a hydroxyl chromone molecule proposed for radical 
scavenging activity. 
 
 
 
 
 
 
 
 
2.2 3D-QSAR modeling 
The MFA model of 35 chromone derivatives (30 compounds in a training set; 5 compounds in a test 
set) was developed using field fit alignment.  The most active compound, 7,8-dihydroxy-2-(4'-
trifluoromethylphenyl)-3-(4''-trifluoromethylbenzoyl)chromone 29 was used as a template model for 
superimposing the rest of the molecules. Superimposition of the aligned molecules is shown in   
Figure 3. 
The steric (CH3) and electrostatic (H
+) descriptors in the MFA-QSAR equations specify the regions 
where variations in the structural features (steric or electrostatic) of different compounds in the 
training set, leading to either an increase or a decrease in activities.  The steric descriptor with positive 
or negative coefficients shows a region where bulky substituent is favored or disfavored, respectively.  
The electrostatic descriptor with a positive coefficient indicates a region favorable for electropositive 
group, while a negative coefficient indicates that an electronegative (electron-withdrawing) group is 
required at the position.  The numbers accompanying descriptors in the equations represent their 
positions in the three-dimensional MFA grid (Figure 4).  The MFA-QSAR equation is expressed as 
follow: 
 
Activity = 2.86587  - 0.021102 (H
+/314) 
                                - 0.004635 (Vm)  
                               + 0.010606 (H
+/336) 
                                - 0.01133 (CH3/663)  
                                - 0.009739 (CH3/670)                                           (1) 
 
n = 30, r = 0.932, r
2 = 0.868, r
2
cv = 0.771, PRESS = 1.022, r
2
BS = 0.857, LSE = 0.02,  
N = 5, r
2
pred = 0.924 
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Figure 3. Superimposition of the aligned molecules in the training set. 
 
 
 
The presence of two steric descriptors (CH3/663) and (CH3/670) with negative coefficients, 
indicates that bulky substituents are disfavored.  The presence of electrostatic descriptor (H
+/336) with 
a positive coefficient on phenyl ring suggests that electropositive groups are favored, while (H
+/314) 
with negative coefficients indicates that electronegative groups should be substituted on benzoyl ring.  
Appearance of descriptor (Vm) with a negative coefficient demonstrates that larger molecule decrease 
activity.  Figure 4 illustrates the regions around the molecule (compound 29) corresponding to the 
MFA model.  This proposed model can be accounted for the lowest activity of compound 31  
(EC50 = 182.77) which possessed no electronegative group in region 3 and electropositive group in 
region 4. 
 
Figure 4. Mapping of the best MFA model and the interaction points.   
The most active compound, 7,8-dihydroxy-2-(4'-trifluoromethylphenyl)-3-(4''-
trifluoromethylbenzoyl)chromone 29, is displayed in background as reference. 
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A QSAR equation is generally acceptable if the correlation coefficient (r) is approximately 0.9 or 
higher.  The r value is a relative measure of the quality of fit of the model.  Its value depends on the 
overall variance of the data.  An r
2
cv, a squared correlation coefficient generated during a cross-
validation procedure, is used as a diagnostic tool to evaluate the predictive power of an equation.  
Cross-validation is often used to determine how large a model (number of terms) can be used for a 
given data set.  Equation 1 explains 86.8% variance in the activity with respect to the steric and 
electrostatic fields and molecular volume while leave-one-out cross-validation power of prediction was 
found to be 77.1%.  An r
2
BS value of 0.857 is an average squared correlation coefficient calculated 
during the validation procedure.  The predictive power of the model was calculated by using the 
following equation 
 
r
2
pred   =   
SD
PRESS) (SD −
                             (2) 
 
where SD is the sum of the squared deviations between the biological activities of each molecules and 
the mean activity of the training set of molecules and PRESS is the sum of squared deviations between 
the predicted and actual activity values for every molecule in the test set. 
The calculated activity obtained from equation 1 and actual activity of the training set and test set 
molecules are summarized in Table 1 and 2.  Scattered plots of calculated and actual activities and the 
plot of residuals for the training set and the test set molecules are shown in Figure 5 and 6, 
respectively.  Most of the molecules showed residual values less than 0.2.  The outlier molecule was 
7,8-dihydroxy-2-(4′-nitrophenyl)-3-(4′′-nitrobenzoyl)chromone 36  (residual = 0.947).  The obtained 
MFA model shows good statistical results with r
2
cv = 0.771, conventional r
2 = 0.868 and r
2
pred = 0.924.   
  
Figure 5. Plot of actual versus calculated log EC50 of the training and test set molecules. 
                                            
0.0
0.5
1.0
1.5
2.0
2.5
0.0 0.5 1.0 1.5 2.0 2.5
Actual log EC50
C
a
l
c
u
l
a
t
e
d
 
l
o
g
 
E
C
5
0
Training set
Test set
Outlier
    Int. J. Mol. Sci. 2008, 9                           
           
 
242
Figure 6. Plot of residuals for training set and test set molecules. 
 
3.  Conclusions  
MFA-QSAR studies were performed on a series of synthetic chromone derivatives using field fit 
alignment with high predictive ability, high cross-validated, conventional and predictive r
2.  The MFA 
equation suggested that electronegative group on benzoyl ring and the electropositive group on phenyl 
ring play an important role for antioxidant activity.  These electronegative and electropositive 
substituents might help in the radical stabilization throughout the chromone nucleus.  The steric 
descriptors indicated that the bulky substituents near position 5 and chromone carbonyl were 
disfavored.  Steric hindrance around these regions may interfere with the planarity between ring A and 
carbonyl group of the chromone nucleus, therefore affecting radical delocalization shown in Figure 2. 
4.  Experimental Section  
4.1 Structures and Biological data 
Chromone derivatives were synthesized by one-pot cyclization reaction with 1,8-
diazabicyclo[5,4,0]undec-7-ene (DBU) as catalyst [25].  The antioxidant activities of the synthesized 
compounds were assessed on the basis of the radical scavenging effect on the DPPH free radicals as 
described previously [16].  The concentrations of test samples required to scavenge 50% of DPPH free 
radicals (EC50 µM) were converted into corresponding log EC50 values. 
4.2 Molecular structure generation  
The molecular structures of chromone derivatives were modeled with SYBYL 7.0 molecular 
modeling program (Tripos Associates, Saint Louis, MO) on an Indigo Elan workstation (Silicon 
Graphics Inc., Mountain View, CA) using the sketch approach.  The fragment libraries in SYBYL 
database were used as building blocks for construction of larger images.  Firstly, each structure was 
energy minimized using the standard Tripos force field (Powell method and 0.05 kcal/mol.Å energy 
gradient convergence criteria) and electrostatic charge was assigned by the Gasteiger-Hückel method.  
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Further, geometry optimization was then carried out with the MOPAC 6 package using the semi-
empirical PM3 with Gasteiger-Hückel for charges calculation.  The SMILESes forms of all structures 
are shown in Table 3. 
 
Table 3.  The SMILESes forms of the synthetic chromone structures. 
 
Cpd  SMILESes form of structures 
1 [H]/C2=C(/Oc1c(O[H])c([H])c([H])c([H])c1C2=O)c3c([H])c([H])c([H])c([H])c3[H] 
2 [H]/C2=C(/Oc1c([H])c(O[H])c([H])c([H])c1C2=O)c3c([H])c([H])c([H])c([H])c3[H] 
3 [H]/C2=C(/Oc1c([H])c(O[H])c([H])c([H])c1C2=O)C([H])([H])c3c([H])c([H])c([H])c([H])c3[H] 
4 [H]/C2=C(/Oc1c([H])c(O[H])c([H])c([H])c1C2=O)c3c([H])c([H])c(N(=O)=O)c([H])c3[H] 
5 [H]/C2=C(/Oc1c([H])c(O[H])c([H])c([H])c1C2=O)c3c([H])c([H])c([H])c(c3[H])C([F])([F])[F] 
6 [H]/C2=C(/Oc1c([H])c(O[H])c([H])c([H])c1C2=O)c3c([H])c([H])c([F])c([H])c3[H] 
7 [H]/C2=C(/Oc1c([H])c(O[H])c([H])c([H])c1C2=O)c3c([H])c(N(=O)=O)c([H])c(N(=O)=O)c3[H] 
8 [H]/C2=C(/Oc1c([H])c(O[H])c([H])c([H])c1C2=O)c3c([H])c([H])c([H])c([Cl])c3[H] 
9 [H]/C2=C(/Oc1c([H])c(O[H])c([H])c([H])c1C2=O)c3c([H])c([H])c(c([H])c3[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([
H])[H] 
10 O=C1C(=C(Oc2c([H])c(O[H])c([H])c([H])c12)c3c([H])c([H])c([H])c([H])c3[H])C([H])([H])[H] 
11 O=C1C(=C(Oc2c([H])c(O[H])c([H])c([H])c12)C([H])([H])c3c([H])c([H])c([H])c([H])c3[H])C([H])([H])[H] 
12 O=C2C(C(=O)c1c([H])c([H])c(N(=O)=O)c([H])c1[H])=C(Oc3c([H])c(O[H])c([H])c([H])c23)c4c([H])c([H])c(N(=O)=O)c([H
])c4[H] 
13 O=C2C(C(=O)c1c([H])c(c([H])c([H])c1[H])C([F])([F])[F])=C(Oc3c([H])c(O[H])c([H])c([H])c23)c4c([H])c([H])c([H])c(c4[
H])C([F])([F])[F] 
14 O=C2C(C(=O)c1c([H])c([H])c([F])c([H])c1[H])=C(Oc3c([H])c(O[H])c([H])c([H])c23)c4c([H])c([H])c([F])c([H])c4[H]  
15 O=C2C(C(=O)c1c([H])c([F])c([F])c([H])c1[H])=C(Oc3c([H])c(O[H])c([H])c([H])c23)c4c([H])c([H])c([F])c([F])c4[H]  
16 O=C2C(C(=O)c1c([H])c([H])c(OC([H])([H])[H])c([H])c1[H])=C(Oc3c([H])c(O[H])c([H])c([H])c23)c4c([H])c([H])c(OC([H]
)([H])[H])c([H])c4[H]  
17 [H]/C2=C(/Oc1c([H])c(O[H])c([H])c(O[H])c1C2=O)c3c([H])c([H])c([H])c(c3[H])C([F])([F])[F]  
18 [H]/C2=C(/Oc1c([H])c(O[H])c([H])c(O[H])c1C2=O)c3c([H])c([H])c([F])c([H])c3[H]  
19 [H]/C2=C(/Oc1c([H])c(O[H])c([H])c(O[H])c1C2=O)c3c([H])c([H])c([F])c([F])c3[H]  
20 [H]/C2=C(/Oc1c([H])c(O[H])c([H])c(O[H])c1C2=O)c3c([H])c([H])c(c([H])c3[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])(
[H])[H]  
21 [H]/C2=C(/Oc1c([H])c(O[H])c([H])c(O[H])c1C2=O)c3c([H])c([H])c([H])c([Cl])c3[H]  
22 [H]/C2=C(/Oc1c([H])c(O[H])c([H])c(O[H])c1C2=O)c3c([H])c([H])c([Cl])c([Cl])c3[H]  
23 [H]/C2=C(/Oc1c([H])c(O[H])c([H])c(O[H])c1C2=O)c3c([H])c([H])c(OC([H])([H])[H])c([H])c3[H]  
24 [H]/C2=C(/Oc1c([H])c(O[H])c([H])c(O[H])c1C2=O)c3c([H])c(OC([H])([H])[H])c([H])c([H])c3[H]  
25 [H]/C2=C(/Oc1c([H])c(O[H])c([H])c(O[H])c1C2=O)c3c([H])c(N(=O)=O)c([H])c(N(=O)=O)c3[H]  
26 O=C2C(C(=O)c1c([H])c([H])c(N(=O)=O)c([H])c1[H])=C(Oc3c([H])c(O[H])c([H])c(O[H])c23)c4c([H])c([H])c(N(=O)=O)c([
H])c4[H]  
27 [H]/C2=C(/Oc1c(O[H])c(O[H])c([H])c([H])c1C2=O)c3c([H])c([H])c([H])c([H])c3[H]  Int. J. Mol. Sci. 2008, 9                           
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28 [H]/C2=C(/Oc1c(O[H])c(O[H])c([H])c([H])c1C2=O)C([H])([H])c3c([H])c([H])c([H])c([H])c3[H]  
29 O=C2C(C(=O)c1c([H])c(c([H])c([H])c1[H])C([F])([F])[F])=C(Oc3c(O[H])c(O[H])c([H])c([H])c23)c4c([H])c([H])c([H])c(c4
[H])C([F])([F])[F]  
30 O=C2C(C(=O)c1c([H])c([H])c([F])c([H])c1[H])=C(Oc3c(O[H])c(O[H])c([H])c([H])c23)c4c([H])c([H])c([F])c([H])c4[H]  
31 [H]/C2=C(/Oc1c([H])c(O[H])c([H])c([H])c1C2=O)C([H])([H])[H]   
32 [H]/C2=C(/Oc1c([H])c(O[H])c([H])c([H])c1C2=O)c3c([H])c([H])c([Cl])c([Cl])c3[H] 
33 [H]/C2=C(/Oc1c([H])c(O[H])c([H])c(O[H])c1C2=O)c3c([H])c([H])c(N(=O)=O)c([H])c3[H] 
34 [H]/C2=C(/Oc1c(O[H])c(O[H])c([H])c([H])c1C2=O)C([H])([H])[H] 
35 O=C2C(C(=O)c1c([H])c(OC([H])([H])[H])c([H])c([H])c1[H])=C(Oc3c([H])c(O[H])c([H])c([H])c23)c4c([H])c([H])c([H])c(O
C([H])([H])[H])c4[H] 
36 O=C2C(C(=O)c1c([H])c([H])c(N(=O)=O)c([H])c1[H])=C(Oc3c(O[H])c(O[H])c([H])c([H])c23)c4c([H])c([H])c(N(=O)=O)c([
H])c4[H] 
4.3 Structural alignments 
     The  field  fit  alignment  method  was  used  for MFA.  All molecules were submitted to the 
CONFORMER SEARCH module within Cerius
2 to generate 150 conformers of each molecule using 
Boltzman jump method [26].  The lowest energy conformer of each molecule was selected.  All the 
selected conformers were aligned using field fit alignment method in the QSAR module.  The most 
active compound, 7,8-dihydroxy-2-(4'-trifluoromethylphenyl)-3-(4''-trifluoromethylbenzoyl)chromone 
29, was used as a template model for superimposing the rest of the molecules.   
4.4 Molecular field analysis (MFA) 
MFA studies were performed with the QSAR module of Cerius
2.  The molecular field was created 
using CH3 and H
+ as probes representing steric and electrostatic fields, respectively.  The steric and 
electrostatic fields were sampled at each point of regularly spaced grid of 2 Å.  In addition, numerous 
spatial and structural descriptors such as polarizability, dipole moment, radius of gyration, molecular 
area, molecular dimension, density, principal moment of inertia, molecular volume, molecular weight, 
number of rotatable bonds, hydrogen bond donors and acceptors, log P, molar refractivity and others 
were also calculated and considered as independent variables.  Only 10% of the total descriptors with 
the highest variance were considered for further analysis.  Regression analysis was carried out using 
genetic partial least squares (G/PLS) method consisting of 5000 generations with a population size of 
100.  The optimum number of components was set to 4 based on better r
2 and r
2
cv values for a given 
training set.  An energy cutoff of ± 30.0 kcal/mol was set for both steric and electrostatic contributions.  
The smoothing parameter, d, was set to 1.0 to control the bias in the scoring factors between equations 
with different number of terms.  The length of the final equation was fixed to five descriptors.  The 
linear option was used in the equation creation.  Cross validation was performed with the leave-one-
out procedure.  The PLS analysis was set to no scale. Int. J. Mol. Sci. 2008, 9                           
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